Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Surgical Wound Infection 5 Neoplasms 4 Colorectal Neoplasms 4 Sepsis 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Leukemia, Myeloid, Acute 2 Febrile Neutropenia 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solitary Pulmonary Nodule 1 Skin Neoplasms 1 Pancreatic Fistula 1 Neutropenia 1 Neoplasms, Plasma Cell 1 Multiple Pulmonary Nodules 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Intestinal Neoplasms 1 Inflammation 1 Infections 1 Hematologic Neoplasms 1 Glioblastoma 1 Fever 1 Exanthema 1 Emergencies 1

Interventions

pegfilgrastim 30 Filgrastim 29 Cyclophosphamide 10 pegylated granulocyte colony-stimulating factor 8 Docetaxel 8 Etoposide 7 Cytarabine 7 Ciprofloxacin 6 Cefepime 6 Vancomycin 5 Leucovorin 5 Fluorouracil 5 eflapegrastim 4 Granulocyte Colony-Stimulating Factor 4 Doxorubicin 4 Peripheral Blood Stem Cell Transplantation 3 Mitoxantrone 3 Methotrexate 3 Levofloxacin 3 Irinotecan 3 Idarubicin 3 Daunorubicin 3 Cyclosporine 3 Caspofungin 3 Carboplatin 3 Amikacin 3 trifluridine tipiracil drug combination 2 plerixafor 2 liposomal amphotericin B 2 Vincristine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neutropenia × Anti-Bacterial Agents × Clear all

NCT03768869 2021-04-27

Fever and Neutropenia in Pediatric Oncology Patients

University of Colorado, Denver

Phase 3 Withdrawn

Fever, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡